Portugália is expanding in Macau, targeting Hong Kong, and returning to Hengqin. CEO Francisco Carvalho Martins sees Macau as ...

Sands China has retained its leading position in Macau’s GGR market share, though Galaxy Entertainment narrowed the gap in Q4 ...

Hong Kong and Macau delegates to the country's top political advisory body said the two SARs should make good use of their ...

Galaxy Entertainment Group ( GEG) Chairman Francis Lui expressed optimism on Thursday about Macau’s ability to reach its 2025 ...

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

Tu Haiming of China’s top advisory body issues call at meeting amid Beijing’s most important annual political gathering, ...

WHARF REIC Annual Underlying NP Hikes 2% to $6.14B; 2nd Interim DPS $0.6 ...

BIIB's TRANSCEND phase III study on felzartamab in adult kidney transplant recipients diagnosed with late AMR is set to enroll approximately 120 patients.

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Based on DICJ reporting, Macau's Gross Gaming Revenue ("GGR”) for full year 2024 was $220.2 billion, up 24% year-on-year, and represented 78% of 2019 level. GGR in Q4 2024 was $55.8 billion, up 6% ...

Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...